Humacyte, Inc. (HUMA) Misses Q3 EPS by 2c

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $236.02 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
• Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
• Fervo Energy Company (FRVO) Reports Q2 Loss of $0.38